Malignant central nervous system neoplasm – Diagnostics – Overview of Information and Clinical Research

Understanding how central nervous system tumors are diagnosed is a crucial first step in managing these complex conditions. From recognizing early warning signs to undergoing specialized imaging and tissue analysis, the diagnostic journey helps healthcare teams determine the best course of action for each individual patient.

Introduction: Who Should Seek Diagnostic Testing

If you experience persistent symptoms that affect how your brain or spinal cord functions, it’s important to seek medical attention. Not everyone with a headache or occasional dizziness has a brain tumor, but certain warning signs should prompt you to visit a healthcare professional. People who develop new, ongoing headaches that differ from their usual pattern, especially if these headaches worsen in the morning or are accompanied by vomiting, should consider getting evaluated.^[1]

Seizures that occur for the first time in adults without a prior history of epilepsy are another important reason to seek diagnostic testing. Changes in your ability to see, hear, or speak clearly can also signal that something is affecting your brain. Some people notice personality changes, difficulty concentrating, or problems with memory that don’t match their usual behavior. Weakness or numbness that appears on one side of the body, balance problems, or unexplained dizziness are additional symptoms that warrant medical investigation.^[3]

Children may show different warning signs than adults. Parents should watch for behavioral changes, developmental delays, abnormal head positioning, or growth problems that seem unusual. Excessive thirst, reduced consciousness, or new onset seizures in a child should prompt immediate medical consultation.^[9]

The symptoms you experience depend greatly on where a tumor is located in your brain or spinal cord and how large it has grown. A tumor in one area might cause vision problems, while a tumor in another region might affect your ability to walk or move your arms. Because the brain controls so many different body functions, tumors in different locations create different symptoms.^[1]

⚠️ Important

Some parts of the brain are less active than others in controlling day-to-day functions. If a tumor begins growing in one of these quieter areas, you might not notice any symptoms until the tumor becomes quite large. This is why some brain tumors are discovered at a more advanced stage, even though they’ve been growing for some time without causing noticeable problems.^[3]

Classic Diagnostic Methods

When you visit a healthcare provider with symptoms that suggest a possible brain or spinal cord tumor, the diagnostic process typically begins with a thorough neurological examination. This is not a single test but rather a series of assessments that evaluate how different parts of your nervous system are functioning. Your doctor will check your vision, hearing, balance, coordination, strength, and reflexes. They may test how well you can feel sensations in different parts of your body and assess your ability to walk and maintain posture.^[1]

The neurological exam helps identify which part of your brain or spinal cord might be affected. For example, if you have weakness on only one side of your body, this suggests a problem in a specific brain region. Trouble in one or more areas during these tests provides important clues about where to look for a problem, though the exam itself cannot confirm whether a tumor is present.^[1]

After the initial examination, imaging tests become the cornerstone of diagnosis. A computed tomography scan, commonly called a CT scan, uses X-rays to create detailed pictures of the inside of your head or spine. Because CT scanners are widely available and produce results quickly, this test is often performed first, especially when symptoms have many possible causes. The images can detect abnormalities in and around the brain, giving your healthcare team important information about whether further testing is needed.^[17]

If a CT scan reveals something suspicious, or if your doctor strongly suspects a brain tumor based on your symptoms, the next step is usually a magnetic resonance imaging scan, or MRI. An MRI uses powerful magnets and radio waves instead of X-rays to create highly detailed images of your brain and spinal cord. This test shows the brain more clearly than a CT scan and can detect smaller tumors that might not appear on other imaging tests.^[17]

During an MRI, you often receive an injection of a special dye, called contrast material, into a vein in your arm. This dye helps make certain details more visible and makes it easier to see smaller tumors. The contrast also helps healthcare providers distinguish between tumor tissue and normal, healthy brain tissue. Sometimes specialized types of MRI are performed to gather even more specific information about a suspected tumor.^[17]

A biopsy provides the definitive diagnosis of a central nervous system tumor. During this procedure, a small sample of tissue is removed from the suspicious area and examined under a microscope. The biopsy tells doctors exactly what type of cells are present and whether they are cancerous or noncancerous. This information is essential because treatment decisions depend heavily on the specific type of tumor identified.^[1]

Sometimes a biopsy is performed as a separate procedure before any treatment begins. In other cases, tissue is obtained during surgery to remove the tumor. A pathologist, a doctor who specializes in analyzing tissue samples, examines the cells to determine their characteristics and how aggressive they are. The results help predict how the tumor might behave and guide the choice of treatment approaches.^[17]

However, there are situations where obtaining a biopsy is not possible. Some tumors are located in parts of the brain that are too dangerous to access surgically without causing serious damage to vital brain functions. In these cases, doctors must rely on imaging studies and the clinical picture to make treatment decisions. While this is not ideal, experienced medical teams can often make informed recommendations based on how the tumor appears on scans and how symptoms develop over time.^[1]

⚠️ Important

If you are told that your tumor cannot be biopsied or operated on, consider seeking a second opinion from another neurosurgeon. Different surgeons have varying levels of skill, experience, and access to specialized techniques. What one surgeon considers inoperable might be approachable by another specialist using different methods or equipment. Getting multiple expert opinions can help ensure you have explored all possible options.^[1]

Additional Diagnostic Tools

Beyond standard imaging, other specialized tests may be used to gather more information about a suspected tumor. Magnetic resonance spectroscopy is an advanced form of MRI that can analyze the chemical composition of brain tissue, helping to distinguish tumor tissue from other conditions like infection or inflammation. This test is not always necessary but can provide valuable additional information in complex cases.^[9]

For tumors located in or near the spinal cord, similar imaging approaches are used. Spinal MRI scans can show tumors growing within the spinal cord itself or pressing on it from outside. These images help doctors understand the tumor’s relationship to important nerve structures and plan the safest approach for biopsy or treatment.^[1]

In some cases, doctors may order additional blood tests or other laboratory studies, though these are generally not the primary way to diagnose brain tumors. Unlike some other cancers, brain tumors typically do not cause changes in routine blood work. However, certain types of brain tumors, particularly those affecting hormone-producing glands like the pituitary, can cause hormonal imbalances that show up in blood tests.^[4]

Diagnostics for Clinical Trial Qualification

When patients consider participating in clinical trials—research studies testing new treatments for brain and spinal cord tumors—they must undergo specific diagnostic procedures to determine whether they qualify. Clinical trials have strict eligibility criteria designed to ensure that the experimental treatment is tested in appropriate patients and that results can be properly interpreted.

One of the most fundamental requirements for enrolling in most clinical trials is confirmation of the tumor type through biopsy. Researchers need to know exactly what kind of tumor a patient has because treatments being studied are often designed for specific tumor types. The tissue obtained during biopsy undergoes detailed analysis, and in many trials, this analysis must be performed or confirmed at specific laboratories that can provide standardized results.^[1]

Modern clinical trials increasingly require molecular and genetic testing of tumor tissue. Scientists have discovered that tumors with certain genetic characteristics respond differently to treatments than tumors without those characteristics. For example, some trials for patients with oligodendroglioma specifically require that the tumor has a genetic feature called 1p/19q codeletion. This genetic marker helps predict how the tumor will respond to treatment and affects patient outcomes.^[14]

Baseline imaging studies are essential for trial participation. Before starting any experimental treatment, patients typically need recent MRI scans that clearly show the tumor’s size, location, and characteristics. These baseline images serve as a reference point for measuring whether the treatment is working. Throughout the trial, patients undergo regular repeat imaging at specified intervals so researchers can track changes in the tumor.^[13]

Many trials also require assessment of the patient’s overall physical condition and ability to function in daily life. Doctors use standardized scales to rate how well patients can care for themselves and perform normal activities. This assessment, often called performance status, helps determine whether a patient is healthy enough to tolerate the experimental treatment being tested. Patients who are too weak or debilitated may not be eligible for trials of intensive therapies.^[12]

Blood tests are frequently required before and during clinical trial participation. These tests check organ function, particularly of the kidneys, liver, and bone marrow, to ensure that the patient can safely receive the treatment being studied. Many cancer treatments can affect these organs, so doctors need to confirm they are functioning adequately before treatment begins. Blood counts that measure red blood cells, white blood cells, and platelets are especially important.^[13]

For trials testing treatments that might affect specific body systems, additional specialized tests may be required. For instance, if a treatment could potentially affect heart function, patients might need an electrocardiogram or echocardiogram before enrollment. If the treatment might affect vision, a comprehensive eye examination might be necessary. These precautionary tests help protect patient safety by identifying anyone who might be at increased risk of complications.^[12]

Documentation of previous treatments is another critical component of trial eligibility. Many trials are designed for patients whose tumors have returned after initial treatment, while others specifically recruit patients who have not yet received any therapy. Detailed medical records showing what treatments were given, when they were given, and how the tumor responded help determine whether a patient fits the trial’s target population.

Some clinical trials require a fresh biopsy of the tumor specifically for the study, even if a previous biopsy confirmed the diagnosis. This is because researchers may want to study the tumor’s current genetic and molecular characteristics, which can change over time, especially after previous treatments. While undergoing an additional biopsy solely for research purposes is a significant consideration, it provides valuable information that advances scientific understanding of these tumors.^[13]

Prognosis and Survival Rate

Prognosis

The outlook for patients with central nervous system tumors varies dramatically depending on multiple factors. The type of tumor has the most significant impact on prognosis—some tumors are slow-growing and may not require immediate treatment, while others are aggressive and require swift medical intervention. Certain factors consistently influence outcomes: younger patients generally have better outcomes than older adults; the patient’s overall health and ability to function normally at diagnosis matters significantly; and how much of the tumor can be safely removed during surgery affects long-term results.^[1]

For the most aggressive type of brain tumor, glioblastoma multiforme, the prognosis remains challenging. Older adults with this disease rarely live longer than one year, though younger patients may have somewhat longer survival times. Age serves as an important predictor of survival across most brain tumor types, as does the patient’s level of neurological functioning when treatment begins. In contrast, some childhood tumors like medulloblastoma have seen significant improvements in survival rates due to better identification of risk types and improved treatment approaches.^[5]

Location of the tumor within the brain or spinal cord influences both treatment options and outcomes. Tumors in areas that control vital functions like breathing or heart rate pose greater surgical challenges than those in less critical regions. Similarly, tumors that can be completely removed surgically generally have better outcomes than those that can only be partially removed or cannot be operated on at all. The ability to achieve complete surgical removal, called gross total resection, is one of the most important factors affecting how long patients survive.^[12]

Survival Rate

Data from the Surveillance, Epidemiology, and End Results Program for 2017 to 2021 indicates that the combined incidence of brain and other central nervous system tumors in the United States was 6.2 cases per 100,000 people per year, with a mortality rate of 4.4 deaths per 100,000 people per year based on deaths from 2018 to 2022. In general, the incidence of primary CNS tumors is higher in White individuals than in Black individuals, and mortality is higher in men than in women.^[13]

For patients with glioblastoma, average survival remains between 10 to 15 months despite aggressive treatment. However, survival varies considerably based on age and other factors—younger patients in their twenties may have a five-year survival rate around 22%, while those in their fifties and sixties typically have a five-year survival rate closer to 6%. In contrast, patients with certain types of ependymoma, a less aggressive tumor type, have significantly better outcomes, with five-year survival rates reaching 87% to 92% depending on age.^[5]

It’s crucial to remember that survival statistics represent averages across many patients and cannot predict exactly what will happen to any individual person. Some patients exceed the average expectations considerably, especially as new treatments continue to emerge. Factors like response to treatment, access to specialized care, participation in clinical trials, and overall support systems all contribute to individual outcomes that may differ from statistical averages.^[12]

#1 Clinical Trials Search in Europe